StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/302% below fair value
$27.39+0.43 (+1.59%)

Close on Nov 18, 2026Market cap $4.55BP/E –Yield –

Ionis Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ionis Pharmaceuticals's pe ratio was 773.4× on Jan 31, 2023, against 29.2× a year earlier. Over the last 4 years it ranged from 5.6× to 791.3×, with a median of 50.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023773.4×+40.7
2022Dec 30, 2022732.7×+638.8
2021Jan 29, 202193.9×+5.5
2020Dec 31, 202088.3×+68.2
2019Dec 31, 201920.1×−266.7
2018Apr 30, 2018286.9×+77.3
2017Dec 29, 2017209.6×−179.7
2016Jan 29, 2016389.3×−230.0
2015Dec 31, 2015619.3×+612.5
2010Apr 30, 20106.8×–

More Ionis Pharmaceuticals figures

See a number that looks wrong?